Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shangqiu Baiyunshan Dongtai Pharmaceutical is a specialized pharmaceutical manufacturer located in Shangqiu, Henan Province, China, and operates as a key subsidiary of the Guangzhou Baiyunshan Pharmaceutical Group. The company focuses on the research, development, and large-scale production of both Traditional Chinese Medicines (TCM) and chemical generic pharmaceuticals. Its product portfolio is particularly well-regarded in the fields of pediatrics, cardiovascular health, and digestive medicine, featuring flagship products such as Xiaoer Xiaoshi Pian and Fufang Danshen Pian. The company maintains modern, GMP-certified production facilities for various dosage forms, including tablets, capsules, and granules. As an integral part of the "Baiyunshan" brand ecosystem, it serves as a major manufacturing hub for the group in Central China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baiyunshan Dongtai Shangqiu Pharmaceutical.